Coinspeaker ABBV Stock Rises 4.50%, JPMorgan Upgraded AbbVie to Overweight from NeutralJPMorgan upgraded AbbVie (ABBV) stock to Overweight from Neutral. The price target was raised to $105 from $85. The current stock price is around $91.ABBV Stock Rises 4.50%, JPMorgan Upgraded AbbVie to Overweight from Neutral